Onyx (ONXX) Updates on FY12 Ops, Achievements; Plans Kyprolis Phase 3 in FY13
Tweet Send to a Friend
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) reviewed 2012 accomplishments and announced several 2013 business updates, which the company discussed during its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE